292 related articles for article (PubMed ID: 25394725)
1. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
[TBL] [Abstract][Full Text] [Related]
2. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions.
Teyateeti A; Tocharoenchai C; Muangsomboon K; Komoltri C; Pusuwan P
J Med Assoc Thai; 2017 Jan; 100(1):100-10. PubMed ID: 29911774
[TBL] [Abstract][Full Text] [Related]
4. Beware of the focal uptake at the ischium on the bone scan in prostate cancer.
Hassan FU; Mohan HK; Gnanasegaran G; Vijayanathan S; Fogelman I
Nucl Med Commun; 2011 Apr; 32(4):320-3. PubMed ID: 21224744
[TBL] [Abstract][Full Text] [Related]
5. Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT.
Sharma P; Dhull VS; Reddy RM; Bal C; Thulkar S; Malhotra A; Kumar R
Diagn Interv Radiol; 2013; 19(1):33-40. PubMed ID: 22865157
[TBL] [Abstract][Full Text] [Related]
6. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.
Utsunomiya D; Shiraishi S; Imuta M; Tomiguchi S; Kawanaka K; Morishita S; Awai K; Yamashita Y
Radiology; 2006 Jan; 238(1):264-71. PubMed ID: 16304081
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
10. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.
Römer W; Nömayr A; Uder M; Bautz W; Kuwert T
J Nucl Med; 2006 Jul; 47(7):1102-6. PubMed ID: 16818944
[TBL] [Abstract][Full Text] [Related]
11. [The use of SPECT-CT with 99mTc-labeled phosphates in patients with suspected skeletal metastases in planar bone scintigraphy].
Krzhivitskiĭ PI; Kanaev SV; Novikov SN; Zhukova LA; Krivorot'ko PV; Ponomareva OI; Negustorov IuF
Vopr Onkol; 2013; 59(5):611-9. PubMed ID: 24260890
[TBL] [Abstract][Full Text] [Related]
12. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.
Helyar V; Mohan HK; Barwick T; Livieratos L; Gnanasegaran G; Clarke SE; Fogelman I
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):706-13. PubMed ID: 20016889
[TBL] [Abstract][Full Text] [Related]
13. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
Kolade OU; Brink A; Ayeni AO; More S; Holness J
Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
[TBL] [Abstract][Full Text] [Related]
14. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
[TBL] [Abstract][Full Text] [Related]
15. The role of SPECT/CT in skeletal malignancies.
Ghosh P
Semin Musculoskelet Radiol; 2014 Apr; 18(2):175-93. PubMed ID: 24715449
[TBL] [Abstract][Full Text] [Related]
16. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management.
Sharma P; Singh H; Kumar R; Bal C; Thulkar S; Seenu V; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):139-47. PubMed ID: 22157698
[TBL] [Abstract][Full Text] [Related]
17. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
Zhang Y; Shi H; Li B; Cai L; Gu Y; Xiu Y
Nuklearmedizin; 2015; 54(6):255-61. PubMed ID: 26615876
[TBL] [Abstract][Full Text] [Related]
18. SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.
Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
Clin Nucl Med; 2018 Apr; 43(4):225-231. PubMed ID: 29401151
[TBL] [Abstract][Full Text] [Related]
19. Inter observer reproducibility of SPECT-low dose CT in classifying indeterminate lesion on planar bone scan in oncologic diseases.
Biyi A; Oufroukhi Y; Doudouh A
Tunis Med; 2017 Feb; 95(2):126-131. PubMed ID: 29424872
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse.
Su HC; Zhu Y; Ling GW; Hu SL; Xu XP; Dai B; Ye DW
Asian J Androl; 2017; 19(3):267-271. PubMed ID: 27976632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
